BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26122471)

  • 1. The AT-hook DNA binding ability of the Epstein Barr virus EBNA1 protein is necessary for the maintenance of viral genomes in latently infected cells.
    Chakravorty A; Sugden B
    Virology; 2015 Oct; 484():251-258. PubMed ID: 26122471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome.
    Lee EK; Kim SY; Noh KW; Joo EH; Zhao B; Kieff E; Kang MS
    Antiviral Res; 2014 Apr; 104():73-83. PubMed ID: 24486954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
    Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
    Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a high-throughput screen for inhibitors of Epstein-Barr virus EBNA1.
    Thompson S; Messick T; Schultz DC; Reichman M; Lieberman PM
    J Biomol Screen; 2010 Oct; 15(9):1107-15. PubMed ID: 20930215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells.
    Yin Q; Flemington EK
    Virology; 2006 Mar; 346(2):385-93. PubMed ID: 16343579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
    Deakyne JS; Malecka KA; Messick TE; Lieberman PM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes.
    Sears J; Ujihara M; Wong S; Ott C; Middeldorp J; Aiyar A
    J Virol; 2004 Nov; 78(21):11487-505. PubMed ID: 15479791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
    Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
    Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
    Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
    mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DNA segregation mechanism of Epstein-Barr virus nuclear antigen 1.
    Wu H; Ceccarelli DF; Frappier L
    EMBO Rep; 2000 Aug; 1(2):140-4. PubMed ID: 11265753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth.
    Messick TE; Smith GR; Soldan SS; McDonnell ME; Deakyne JS; Malecka KA; Tolvinski L; van den Heuvel APJ; Gu BW; Cassel JA; Tran DH; Wassermann BR; Zhang Y; Velvadapu V; Zartler ER; Busson P; Reitz AB; Lieberman PM
    Sci Transl Med; 2019 Mar; 11(482):. PubMed ID: 30842315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
    Liu CD; Lee HL; Peng CW
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient replication of Epstein-Barr virus-derived plasmids requires tethering by EBNA1 to host chromosomes.
    Hodin TL; Najrana T; Yates JL
    J Virol; 2013 Dec; 87(23):13020-8. PubMed ID: 24067969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4.
    Lin A; Wang S; Nguyen T; Shire K; Frappier L
    J Virol; 2008 Dec; 82(24):12009-19. PubMed ID: 18922874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
    Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM
    J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer.
    Mansouri S; Pan Q; Blencowe BJ; Claycomb JM; Frappier L
    J Virol; 2014 Oct; 88(19):11166-77. PubMed ID: 25031339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections.
    Malik-Soni N; Frappier L
    J Virol; 2012 Jun; 86(12):6999-7002. PubMed ID: 22496234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus nuclear antigen 1 (EBNA1) induced cytotoxicity in epithelial cells is associated with EBNA1 degradation and processing.
    Jones RJ; Smith LJ; Dawson CW; Haigh T; Blake NW; Young LS
    Virology; 2003 Sep; 313(2):663-76. PubMed ID: 12954232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
    Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
    J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.